Isabelle Mahé on Delphi Consensus on Aspects Relating to the Antithrombotic Therapy for Cancer Patients
Isabelle Mahé, Head of Internal Medicine, Louis Mourier Hospital, APHP, Paris Cité University, reposted from SERENITY on LinkedIn:
”A two-round Delphi process was used to achieve consensus on aspects relating to the antithrombotic therapy deprescribing discussions and process in end-of-life cancer patients across Europe and different specialities.
The perspective is to support informed decision-making, reduce complications, and improve quality of life in palliative care patients.”
Quoting SERENITY‘s post:
”Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Results of a European Delphi study
For the DELPHI Serenity Group
Isabelle Mahé Anette Arbjerg Højen
Prof.Dr.Stavros Konstantinides
Sebastian Szmit
Denise Abbel
Laurent Bertoletti
Adrian Edwards
Jacobijn Gussekloo
Johan Langendoen
Simon Mooijaart
Stella Trompet
Erik Klok
Professor Simon Noble
Camille Couffignal”
Read the full article here.
Article: Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Results of a European Delphi study
Authors: For the DELPHI Serenity Group – Skerdi Haviarie, Nassima Si Mohammed, Anette Arbjerg Højeng, Carme Fonth, Stavros Konstantinides, Marieke Kruip, Luigi Maiorana, Sebastian Szmit, Denise Abel, Laurent Bertoletti, Adrian Edwards, Michelle Edwards, Alessandra Gaval, Jacobijn Gussekloo, Miriam Johnson, Rashmi Kumar, Johan Langendoen, Kate Lifford, Simon Mooijaart, Mark Pearson, Johanneke Portielje, Kathy Seddon, Stella Trompet, Hélène Helfer, Frederikus Klok, Simon Noble, Camille Couffignal
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 10, 2026, 14:02Pablo Corral: Are Cholesterol and Inflammation Really Equal in Atherosclerosis?
-
Apr 10, 2026, 13:43Mohammed Alo։ How Low Should LDL Go in Secondary Prevention of Cardiovascular Disease
-
Apr 10, 2026, 13:21John Abraham: Telomere Biology Disorders – From Bench to Bedside
-
Apr 10, 2026, 01:19Heghine Khachatryan: When Vascular Fragility Defines Risk – Rethinking Hemostasis in LDS
-
Apr 9, 2026, 21:39Mechanisms of Immune Dysregulation in Immune Thrombocytopenia – JTH
-
Apr 9, 2026, 21:37Arun V J: The Nation Inside the Human Body and Blood Function
-
Apr 9, 2026, 21:36José Antonio García Erce: Fall of While Blood Donation And Apheresis Growth in Spain
-
Apr 9, 2026, 21:34Chokri Ben Lamine: High-Yield Clinical Insights on Carfilzomib-Induced aHUS
-
Apr 9, 2026, 21:29Satyam Arora: Improving Thalassaemia Care in India Through Ground-Level Data